Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection

Gastroenterology

Volumn 143, Issue 5, 2012, Pages

  Patin, Etienne ^a,b   Kutalik, Zoltán ^c,d   Guergnon, Julien ^e   Bibert, Stéphanie ^f   Nalpas, Bertrand ^b,g   Jouanguy, Emmanuelle ^a,b,h   Munteanu, Mona ⁱ   Bousquet, Laurence ^b,g   Argiro, Laurent ^j   Halfon, Philippe ^k   Boland, Anne ^l   Müllhaupt, Beat ^m   Semela, David ⁿ   Dufour, Jean François ^o   Heim, Markus H ^p   Moradpour, Darius ^f   Cerny, Andreas ^q   Malinverni, Raffaele ^r   Hirsch, Hans ^s   Martinetti, Gladys ^t   Suppiah, Vijayaprakash ^u,v   Stewart, Graeme ^u   Booth, David R ^u   George, Jacob ^u   Casanova, Jean Laurent ^a,b,h   Bréchot, Christian ^v   Rice, Charles M ^h   Talal, Andrew H ^w   Jacobson, Ira M ^w   Bourlière, Marc ^x   Theodorou, Ioannis ^e   Poynard, Thierry ^y   Negro, Francesco ^z   Pol, Stanislas ^b,g   Bochud, Pierre Yves ^f   Abel, Laurent ^a,b,h   more..

^a IMAGINE INSTITUTE   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

^d SWISS INSTITUTE OF BIOINFORMATICS   (Switzerland)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^g INSERM   (France)

^h ROCKEFELLER UNIVERSITY   (United States)

ⁱ Biopredictive   (France)

^j Aix Marseille university   (France)

^k Hospital Ambroise Pare   (France)

^l DIF   (France)

^m UNIVERSITY HOSPITAL ZURICH   (Switzerland)

ⁿ CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^o UNIVERSITY OF BERN   (Switzerland)

^p UNIVERSITY HOSPITAL BASEL   (Switzerland)

^q Clinica Moncucco   (Switzerland)

^r Pourtales Hospital   (Switzerland)

^s UNIVERSITY OF BASEL   (Switzerland)

^t Institute of Medical Microbiology   (Switzerland)

^u UNIVERSITY OF SYDNEY   (Australia)

^v Universite Paris Sud   (France)

^w WEILL CORNELL MEDICAL COLLEGE   (United States)

^x HÔPITAL SAINT JOSEPH   (France)

^y SORBONNE UNIVERSITÉ   (France)

^z UNIVERSITY HOSPITAL   (Switzerland)

more..

Author keywords

Cirrhosis; Genetic Analysis; Liver Disease; Risk Factors

Indexed keywords

ANTIOXIDANT; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; GAMMA INTERFERON RECEPTOR 2; INTERLEUKIN 28B; MERTK PROTEIN; PATATIN LIKE PHOSPHOLIPASE 3; PROTEIN; PROTEIN TYROSINE KINASE; RAD18 PROTEIN; TUBBY LIKE PROTEIN 1; UNCLASSIFIED DRUG;

ADULT; APOPTOSIS; ARTICLE; BLOOD TRANSFUSION; CHILD; CHROMOSOME 2; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENOTYPE; HEPATITIS C; HUMAN; LIVER BIOPSY; LIVER FIBROSIS; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; VIRAL CLEARANCE;

EID: 84868157974     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2012.07.097     Document Type: Article

References (75)

1. World Health Organization Hepatitis C Fact sheet no. 164 http://www.who.int/mediacentre/factsheets/fs164/en/ June 2011
2. S.B. Missiha, M. Ostrowski, E.J. Heathcote Disease progression in chronic hepatitis C: modifiable and nonmodifiable factors Gastroenterology 134 2008 1699 1714
3. P.Y. Bochud, T. Cai, K. Overbeck Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C J Hepatol 51 2009 655 666
4. A. Probst, T. Dang, M. Bochud Role of hepatitis C virus genotype 3 in liver fibrosis progression - a systematic review and meta-analysis J Viral Hepat 18 2011 745 759
5. C.H. Osterreicher, F. Stickel, D.A. Brenner Genomics of liver fibrosis and cirrhosis Semin Liver Dis 27 2007 28 43
6. R. Bataller, K.E. North, D.A. Brenner Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal Hepatology 37 2003 493 503
7. H. Huang, M.L. Shiffman, R.C. Cheung Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C Gastroenterology 130 2006 1679 1687
8. H. Huang, M.L. Shiffman, S. Friedman A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C Hepatology 46 2007 297 306
9. B. Nalpas, R. Lavialle-Meziani, S. Plancoulaine Interferon gamma receptor 2 gene variants are associated with liver fibrosis in patients with chronic hepatitis C infection Gut 59 2010 1120 1126
10. A. Alcais, L. Abel, J.L. Casanova Human genetics of infectious diseases: between proof of principle and paradigm J Clin Invest 119 2009 2506 2514
11. A. Balagopal, D.L. Thomas, C.L. Thio IL28B and the control of hepatitis C virus infection Gastroenterology 139 2010 1865 1876
12. P.Y. Bochud, S. Bibert, Z. Kutalik IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes Hepatology 55 2012 384 394
13. J.C. Chambers, W. Zhang, J. Sehmi Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma Nat Genet 43 2011 1131 1138
14. S. Romeo, J. Kozlitina, C. Xing Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease Nat Genet 40 2008 1461 1465
15. X. Yuan, D. Waterworth, J.R. Perry Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes Am J Hum Genet 83 2008 520 528
16. E. Trepo, P. Pradat, A. Potthoff Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C Hepatology 54 2011 60 69
17. L. Valenti, M. Rumi, E. Galmozzi Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C Hepatology 53 2011 791 799
18. L. Prasad, V.M. Spicher, M. Zwahlen Cohort profile: the Swiss Hepatitis C Cohort Study (SCCS) Int J Epidemiol 36 2007 731 737
19. V. Suppiah, M. Moldovan, G. Ahlenstiel IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy Nat Genet 41 2009 1100 1104
20. V. Suppiah, S. Gaudieri, N.J. Armstrong IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European cohort: a cross-sectional study PLoS Med 8 2011 e1001092
21. P. Bedossa, T. Poynard An algorithm for the grading of activity in chronic hepatitis C The METAVIR Cooperative Study Group Hepatology 24 1996 289 293
22. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C Hepatology 20 1994 15 20
23. T. Poynard, P. Bedossa, P. Opolon Natural history of liver fibrosis progression in patients with chronic hepatitis C The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups Lancet 349 1997 825 832
24. R. Sobesky, P. Mathurin, F. Charlotte Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: a dynamic view The Multivirc Group Gastroenterology 116 1999 378 386
25. S. Purcell, B. Neale, K. Todd-Brown PLINK: a tool set for whole-genome association and population-based linkage analyses Am J Hum Genet 81 2007 559 575
26. H. Duan, Y. Wang, M. Aviram SAG, a novel zinc RING finger protein that protects cells from apoptosis induced by redox agents Mol Cell Biol 19 1999 3145 3155
27. C.V. Rothlin, S. Ghosh, E.I. Zuniga TAM receptors are pleiotropic inhibitors of the innate immune response Cell 131 2007 1124 1136
28. N. Chalasani, X. Guo, R. Loomba Genome-wide association study identifies variants associated with histologic features of nonalcoholic fatty liver disease Gastroenterology 139 2010 1567 1576 1576 e1-6
29. V. Kumar, N. Kato, Y. Urabe Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma Nat Genet 43 2011 455 458
30. D. Miki, H. Ochi, C.N. Hayes Variation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriers Nat Genet 43 2011 797 800
31. T. Cai, J.F. Dufour, B. Muellhaupt Viral genotype-specific role of PNPLA3, PPARG, MTTP, and IL28B in hepatitis C virus-associated steatosis J Hepatol 55 2011 529 535
32. P. Banerjee, P.W. Kleyn, J.A. Knowles TULP1 mutation in two extended Dominican kindreds with autosomal recessive retinitis pigmentosa Nat Genet 18 1998 177 179
33. A. Gal, Y. Li, D.A. Thompson Mutations in MERTK, the human orthologue of the RCS rat retinal dystrophy gene, cause retinitis pigmentosa Nat Genet 26 2000 270 271
34. S.A. Hagstrom, M.A. North, P.L. Nishina Recessive mutations in the gene encoding the tubby-like protein TULP1 in patients with retinitis pigmentosa Nat Genet 18 1998 174 176
35. A.I. Su, T. Wiltshire, S. Batalov A gene atlas of the mouse and human protein-encoding transcriptomes Proc Natl Acad Sci U S A 101 2004 6062 6067
36. N.B. Caberoy, Y. Zhou, W. Li Tubby and tubby-like protein 1 are new MerTK ligands for phagocytosis EMBO J 29 2010 3898 3910
37. R.S. Scott, E.J. McMahon, S.M. Pop Phagocytosis and clearance of apoptotic cells is mediated by MER Nature 411 2001 207 211
38. A. Canbay, P. Taimr, N. Torok Apoptotic body engulfment by a human stellate cell line is profibrogenic Lab Invest 83 2003 655 663
39. K. Lauber, E. Bohn, S.M. Krober Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal Cell 113 2003 717 730
40. R. Bataller, R.F. Schwabe, Y.H. Choi NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis J Clin Invest 112 2003 1383 1394
41. A. Canbay, S. Friedman, G.J. Gores Apoptosis: the nexus of liver injury and fibrosis Hepatology 39 2004 273 278
42. S.Y. Kim, J.H. Lee, E.S. Yang Human sensitive to apoptosis gene protein inhibits peroxynitrite-induced DNA damage Biochem Biophys Res Commun 301 2003 671 674
43. K. Machida, G. McNamara, K.T. Cheng Hepatitis C virus inhibits DNA damage repair through reactive oxygen and nitrogen species and by interfering with the ATM-NBS1/Mre11/Rad50 DNA repair pathway in monocytes and hepatocytes J Immunol 185 2010 6985 6998
44. T. Wang, S.A. Weinman Causes and consequences of mitochondrial reactive oxygen species generation in hepatitis C J Gastroenterol Hepatol 21 Suppl 3 2006 S34 S37
45. M.E. Guicciardi, G.J. Gores Apoptosis as a mechanism for liver disease progression Semin Liver Dis 30 2010 402 410
46. W.J. Conover Practical nonparametric statistics 3rd ed. 1999 Wiley New York, NY
47. A.L. Price, N.J. Patterson, R.M. Plenge Principal components analysis corrects for stratification in genome-wide association studies Nat Genet 38 2006 904 909
48. Y. Li, C.J. Willer, J. Ding MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes Genet Epidemiol 34 2010 816 834
49. A.D. Skol, L.J. Scott, G.R. Abecasis Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies Nat Genet 38 2006 209 213
50. T. Johnson, T.R. Gaunt, S.J. Newhouse Blood pressure loci identified with a gene-centric array Am J Hum Genet 89 2011 688 700
51. D.R. Nyholt A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other Am J Hum Genet 74 2004 765 769
52. M.X. Li, J.M. Yeung, S.S. Cherny Evaluating the effective numbers of independent tests and significant p-value thresholds in commercial genotyping arrays and public imputation reference datasets Hum Genet 131 2012 747 756
53. Q. Yi, P.P. Wang, M. Krahn Improving the accuracy of long-term prognostic estimates in hepatitis C virus infection J Viral Hepat 11 2004 166 174
54. C. Backes, A. Keller, J. Kuentzer GeneTrail - advanced gene set enrichment analysis Nucleic Acids Res 35 2007 W186 W192
55. R.J. Pruim, R.P. Welch, S. Sanna LocusZoom: regional visualization of genome-wide association scan results Bioinformatics 26 2010 2336 2337
56. S. Romeo, J. Kozlitina, C. Xing Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease Nat Genet 40 2008 1461 1465
57. N. Chalasani, X. Guo, R. Loomba Genome-wide association study identifies variants associated with histologic features of nonalcoholic fatty liver disease Gastroenterology 139 2010 1567 1576
58. D. Ge, J. Fellay, A.J. Thompson Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance Nature 461 2009 399 401
59. D. Miki, H. Ochi, C.N. Hayes Variation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriers Nat Genet 43 2011 797 800
60. V. Kumar, N. Kato, Y. Urabe Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma Nat Genet 43 2011 455 458
61. B. Nalpas, R. Lavialle-Meziani, S. Plancoulaine Interferon gamma receptor 2 gene variants are associated with liver fibrosis in patients with chronic hepatitis C infection Gut 59 2010 1120 1126
62. H. Huang, M.L. Shiffman, R.C. Cheung Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C Gastroenterology 130 2006 1679 1687
63. H. Huang, M.L. Shiffman, S. Friedman A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C Hepatology 46 2007 297 306
64. J.C. Chambers, W. Zhang, J. Sehmi Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma Nat Genet 43 2011 1131 1138
65. Y. Kamatani, K. Matsuda, Y. Okada Genome-wide association study of hematological and biochemical traits in a Japanese population Nat Genet 42 2010 210 215
66. X. Yuan, D. Waterworth, J.R. Perry Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes Am J Hum Genet 83 2008 520 528
67. C. Tian, R.P. Stokowski, D. Kershenobich Variant in PNPLA3 is associated with alcoholic liver disease Nat Genet 42 2010 21 23
68. T. Cai, J.F. Dufour, B. Muellhaupt Viral genotype-specific role of PNPLA3, PPARG, MTTP, and IL28B in hepatitis C virus-associated steatosis J Hepatol 55 2011 529 535
69. E. Trepo, P. Pradat, A. Potthoff Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C Hepatology 54 2011 60 69
70. L. Valenti, M. Rumi, E. Galmozzi Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C Hepatology 53 2011 791 799
71. V. Suppiah, M. Moldovan, G. Ahlenstiel IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy Nat Genet 41 2009 1100 1104
72. Y. Tanaka, N. Nishida, M. Sugiyama Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C Nat Genet 41 2009 1105 1109
73. A. Rauch, Z. Kutalik, P. Descombes Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study Gastroenterology 138 2010 1338 1345 45e1-7
74. D.L. Thomas, C.L. Thio, M.P. Martin Genetic variation in IL28B and spontaneous clearance of hepatitis C virus Nature 461 2009 798 801
75. P.Y. Bochud, S. Bibert, Z. Kutalik IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes Hepatology 55 2012 384 394